Alloimmunization in Patients with Sickle Cell Disease and Thalassemia: Experience of a Single Centre in Oman.

Alkindi, Salam; AlMahrooqi, Saba; AlHinai, Sumaiya; AlMarhoobi, Ali; Al-Hosni, Saif; Daar, Shahina; Fawaz, Naglaa; Pathare, Anil

Alkindi, Salam; AlMahrooqi, Saba; AlHinai, Sumaiya; AlMarhoobi, Ali; Al-Hosni, Saif; Daar, Shahina; Fawaz, Naglaa; Pathare, Anil.

Afiliação

Alkindi S; College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman; Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman.
AlMahrooqi S; Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman.
AlHinai S; Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman.
AlMarhoobi A; College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman; Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman.
Al-Hosni S; Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman.
Daar S; College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman; Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman.
Fawaz N; Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman.
Pathare A; Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman.

Mediterr J Hematol Infect Dis ; 9(1): e2017013, 2017.

Article em En | MEDLINE | ID: mdl-28293401

Palavras-chave

Alloimmunization; Antibodies; Blood Transfusion; Multitransfused; SCD; Thalassaemia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mediterr J Hematol Infect Dis Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Omã País de publicação: Itália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google